# Parallel18

> Parallel18 is a Puerto Rico-based startup accelerator and investment platform operated by the nonprofit Puerto Rico Science, Technology and Research Trust. It combines P18 international acceleration, BioLeap life sciences incubation, Xpand growth support, corporate introductions, and access to investment resources. Its current P18 offer is $100,000 per selected startup through a SAFE.

- **Founded:** 2015
- **Headquarters:** San Juan, Puerto Rico
- **Founders:** Sebastián Vidal (Founding executive director; accelerator designer), Lucy Crespo (Trust CEO; co-architect of the launch)
- **Products:** P18, Pre18, BioLeap, Xpand, Parallel18 Ventures
- **Notable:** P18 reported 320 graduated companies and $13.3 million in cumulative seed capital in its June 2026 announcement., Announced 16 startups from nine countries and $1.6 million in P18 Gen.14 investment in June 2026., Recognized in TIME and Statista’s 2026 incubator and accelerator ranking; Parallel18 reports position 21 of 80.

## Products & services

- **P18** — Industry-agnostic international accelerator. Current offer: $100,000 via SAFE after four-week virtual evaluation, followed by 16 weeks in Puerto Rico.
- **Pre18** — Historical pre-acceleration program for Puerto Rican startups, developed after Hurricane Maria. Not listed among the current website’s three main programs.
- **BioLeap** — Life sciences and STEM commercialization incubator with 12 weeks of curriculum, 14 weeks of technical assistance, and Confluence Center laboratory access.
- **Xpand** — Free, Banco Popular-subsidized growth community for qualifying Puerto Rico-based companies.
- **Parallel18 Ventures** — Fundraising support and follow-on investment, including the Matching Fund.
- **Parallel18 Connect** — Corporate innovation initiative connecting established companies and startups for potential commercial relationships.
- **Venture Capital Access Program (VCAP)** — Puerto Rico co-investment program implemented by the Economic Development Bank with Parallel18 support; advertised investment range $150,000-$2.5 million and private-capital matching.

## Achievements

- P18 reported 320 graduated companies and $13.3 million in cumulative seed capital in its June 2026 announcement.
- Announced 16 startups from nine countries and $1.6 million in P18 Gen.14 investment in June 2026.
- Recognized in TIME and Statista’s 2026 incubator and accelerator ranking; Parallel18 reports position 21 of 80.
- P18 Gen.13 reported approximately 3,000 additional customers and more than 90 business, investor, and industry connections.

## Latest updates

- **2026-08** — TIME and Statista ranking recognition announced August 18.
- **2026-06** — P18 Gen.14 selection announced June 8; 16-week cohort scheduled to begin July 6.
- **2026-10** — Website checked October 7: BioLeap Gen.4 applications advertised as open; P18 applications stated to reopen in 2027; Xpand advertises year-round applications.

## Links

- Website: https://parallel18.com/
- LinkedIn: https://www.linkedin.com/company/parallel18/
- Twitter/X: https://x.com/p18startups
- Instagram: https://www.instagram.com/p18startups/
- Facebook: https://www.facebook.com/p18startups/

---

Profile page: https://yespress.io/parallel18
Published by YesPress — https://yespress.io
Last updated: 2026-10-07